Immunic Q4 EPS $(0.48) Beats $(0.51) Estimate, Cash And Equivalents As Of December 31, 2023 Were $46.7M
Company Profile
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.